Bloomberg Law
Drug Diagnosis Code Data Sought by HHS OIG May Cue Enforcement
July 12, 2021
Leadership from HHS-OIG recently advocated for new mandates that physicians include a diagnosis code with each prescription and that claims data capture this information. This followed on the heels of a Congressional Research Service report suggesting that Congress should pass legislation requiring healthcare providers to include diagnostic information in prescriptions. As Sidley lawyers Jaime L.M. Jones, Brenna E. Jenny, and Matt Bergs discuss, HHS-OIG may see diagnosis code data as a tool to engage in nuanced investigations into pharmaceutical companies for off-label promotion of prescription drugs, leveraging law enforcement’s increasingly sophisticated capacity to use data analytics to identify targets for investigation.
Contacts

Related Blogs
Capabilities
Suggested News & Insights
DAAG Brenna Jenny Warns Heightened FCA Enforcement Is “The New Normal,” Addresses Enforcement Priorities and PoliciesFebruary 20, 2026DAAG Jenny Reinforces Commitment to FCA Enforcement Premised on “Unlawful DEI”February 20, 2026DOJ Attorneys Underscore Heightened Focus on Trade Fraud During the Annual Qui Tam ConferenceFebruary 19, 2026OIG Releases Long-Awaited Medicare Advantage Compliance Program GuidanceFebruary 10, 2026FY 2025 FCA Settlements and Judgments Statistics Show Highest Recoveries EverJanuary 20, 2026First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
